SEC Form 4 · accession 0001127602-17-010504
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark E Tryniski
Director
Period of report
Mar 6, 2017
Accepted (ET)
Mar 7, 2017 · 9:37 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 6, 2017 | P | 5,000 | $41.15 | A | 27,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.10 to $41.25, inclusive. Full information regarding the number of shares purchased at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.